Human Genome Epidemiology Literature Finder
Records 1 - 5 (of 5 Records) |
Query Trace: Lymphoma and TTF1[original query] |
---|
EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype. The European respiratory journal 2014 Mar 43 (3): 872-83. Warth Arne, Penzel Roland, Lindenmaier Heike, Brandt Regine, Stenzinger Albrecht, Herpel Esther, Goeppert Benjamin, Thomas Michael, Herth Felix J F, Dienemann Hendrik, Schnabel Philipp A, Schirmacher Peter, Hoffmann Hans, Muley Thomas, Weichert Wil |
ALK and ROS1 rearrangements, coexistence and treatment in epidermal growth factor receptor-wild type lung adenocarcinoma: a multicenter study of 732 cases. Journal of thoracic disease 2017 12 9 (10): 3919-3926. Song Zhengbo, Zheng Yuhui, Wang Xuzhou, Su Haiyan, Zhang Yiping, Song Yo |
Molecular genetic alterations in thyroid transcription factor 1-negative lung adenocarcinoma in cytology specimens: A subset with aggressive behavior and a poor prognosis. Cancer cytopathology 2018 Sep . Rodriguez Erika F, VandenBussche Christopher J, Chowsilpa Sayanan, Maleki Zah |
[Histologic subtyping of poorly-differentiated solid lung cancer with molecular testing for epidermal growth factor receptor mutation and ALK gene rearrangement: an analyses of 167 cases]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2018 Jun 47 (6): 432-437. Fang F, Wang Y X, Hu S T, Yang L, Di J, Liu D G, Lyu |
Correlation between Programmed Death Ligand-1(PD-L1) Expression and Driver Gene Mutations in Non-Small Cell Lung Carcinoma- Adenocarcinoma Phenotype. Asian Pacific journal of cancer prevention : APJCP 2022 Jan 23 (1): 131-142. Pandey Rahul Kumar, Shukla Saumya, Husain Nuzhat, Islam Mohammad Hayatul, Hadi Rahat, Kant Tripathi Surya, Singhal Ashi |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: